Literature DB >> 16193995

Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test.

He Hong-Xuan1, Chen Lei, Wang Cheng-Min, Zhou Kai, Tang Yi, Qin Xi-Ming, Duan Ming-Xing.   

Abstract

The CP15 and CP23 surface proteins on the sporozoite of Cryptosporidium parvum are major protective antigens. The recombinant plasmid pET28-15-23 was constructed based on the plasmids pMD18-T-15 and pMD18-T-23 with two pairs of specific primers using DNA recombinant technique. In the primers, a synthetic linker sequence encoding a peptide (G-G-S) was designed. After identification, the recombinant plasmids were transformed to component cells of Escherichia coli BL21 (DE3). The positive strain containing the recombinant plasmid could express a specific fusion protein (CP15-23, MW approximately 25 kDa) induced by IPTG. The fusion protein could be recognized by the positive serum of mice infected with Cryptosporidium parvum oocysts specifically. The BALB/c mice were immunized with 80 microg of CP15-23 protein 4 times at 2 week intervals. The mice produced specific antibodies that responded to the lysate of Cryptosporidium parvum oocysts and could prevent Cryptosporidium parvum infection. The results indicated that the recombinant fusion protein CP15-23 would be used as a candidate antigen to prevent cryptosporidiosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193995     DOI: 10.1166/jnn.2005.210

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  7 in total

1.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.

Authors:  Sitara Swarna Rao Ajjampur; Rajiv Sarkar; Geneve Allison; Kalyan Banda; Anne Kane; Jayaprakash Muliyil; Elena Naumova; Honorine Ward; Gagandeep Kang
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

3.  Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species.

Authors:  Patricio A Manque; Fernando Tenjo; Ute Woehlbier; Ana M Lara; Myrna G Serrano; Ping Xu; João M Alves; Ronald B Smeltz; Daniel H Conrad; Gregory A Buck
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

Review 4.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

5.  Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.

Authors:  Humphrey N Ehigiator; Pablo Romagnoli; Jeffrey W Priest; W Evan Secor; Jan R Mead
Journal:  Parasitol Res       Date:  2007-05-09       Impact factor: 2.289

6.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

Review 7.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.